For patients with high ERIs, drugs other than EPO can be used to increase the hemoglobin level of MHD patients and prevent the occurrence of cardiovascular and cerebrovascular diseases caused by the side effects of high-dose EPO application. Here, EPO is linked to cerebrovascular disorder.